相关实验视频

Updated: Jun 24, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

用于治疗子宫内膜癌的多斯塔利马布:一篇评论

Chelsea E Stewart¹, Dana Chase¹

¹Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, USA.

Touch reviews in oncology & haematology

|June 10, 2024

概括

现在,多斯塔利马布已获得FDA批准,用于前线治疗异位修复缺陷 (dMMR) 患者的子宫内膜癌,并进行化疗. 本综述涵盖了支持dMMR子宫内膜瘤治疗这一重大进展的证据.

科学领域:

妇科瘤学妇科瘤学
医学瘤学医学瘤学
免疫治疗是一种免疫疗法.

背景情况:

子宫内膜癌的治疗已经发展,特别是对不匹配修复缺陷 (dMMR) 亚型的治疗.
美国食品和药物管理局 (FDA) 最近批准了针对这一群体的新疗法.

研究的目的:

审查关键的出版物和研究,以告知FDA批准duralimab.
为了突出dolarlimab在治疗dMMR子宫内膜癌中的疗效和安全性.

主要方法:

关于在子宫内膜癌中使用达尔利马布的研究的文献综述.
分析临床试验数据和出版物,以获得FDA批准.

主要成果:

多斯塔利马布在dMMR子宫内膜癌中显示出良好的安全性和已证明的疗效.
这种免疫检查点抑制剂代表了前线治疗的实践改变的进步.

结论:

多斯塔利马布与化疗结合,是对前线dMMR子宫内膜癌的新标准治疗.
对不匹配修复性子宫内膜癌的治疗选择仍然有限.

关键词:

检查点抑制剂检查点抑制剂化学疗法化疗化疗提供可靠的服务.子宫内膜瘤的新生体.免疫疗法免疫疗法不匹配修复缺陷缺陷

更多相关视频

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...